文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

新型冠状病毒肺炎患者院内心脏骤停后的心肺复苏是否徒劳

Is Cardiopulmonary Resuscitation Futile in Coronavirus Disease 2019 Patients Experiencing In-Hospital Cardiac Arrest?
PubMed 文献 · Crit Care Med · 2021-01-01
一句话结论在新型冠状病毒肺炎患者院内心脏骤停并尝试复苏的队列中,尽管29%恢复自主循环,但均为短暂,院内死亡率为100%。

该回顾性队列研究描述了美国农村西南乔治亚州单中心多医院中连续63例新型冠状病毒肺炎院内心脏骤停并尝试复苏患者的特征与结局。患者中位年龄66岁,90.5%为非裔美国人,84.1%在ICU发生心脏骤停,最常见初始心律为无脉性电活动(58.7%)和无收缩(33.3%)。29%患者恢复自主循环但均短暂,院内死亡率为100%,与基线合并症、疾病严重程度及骤停地点无关。

要点

  • 在63例新型冠状病毒肺炎院内心脏骤停并尝试复苏患者中,尽管29%恢复自主循环,但均为短暂,院内死亡率为100%。
  • 84.1%的院内心脏骤停发生在ICU,最常见初始心律为无脉性电活动(58.7%)和无收缩(33.3%)。
  • 骤停前81%患者使用呼吸机,60.3%使用血管升压药,39.7%接受透析。
  • 所有ICU内骤停的高级心脏生命支持启动时间小于1分钟,其余患者小于2分钟。
  • 院内死亡率100%与基线合并症、疾病严重程度及骤停地点无关。

适用人群与场景

  • 连续新型冠状病毒肺炎患者发生院内心脏骤停并尝试复苏者。
  • 研究期间共有1094例因新型冠状病毒肺炎住院患者,其中63例发生院内心脏骤停并尝试复苏并纳入研究。

处置流程与药物剂量

  • 对院内心脏骤停患者尝试进行高级心脏生命支持复苏。
  • ICU内所有院内心脏骤停的高级心脏生命支持方案启动时间小于1分钟,其余患者小于2分钟。

研究设计与关键结果

  • 研究为回顾性队列研究,单中心多医院,纳入63例新型冠状病毒肺炎院内心脏骤停并尝试复苏患者。
  • 患者中位年龄66岁,49.2%为男性,90.5%为非裔美国人。
  • 最常见合并症为高血压(88.9%)、肥胖(69.8%)、糖尿病(60.3%)和慢性肾脏病(33.3%);18例(28.9%)Charlson合并症指数为0-2。
  • 最常见就诊症状为呼吸困难(63.5%)、发热(52.4%)和咳嗽(46%);入院前症状中位持续时间为14天。
  • 住院期间66.7%患者发生脓毒性休克,84.1%发生急性呼吸窘迫综合征。
  • 骤停前81%使用呼吸机,60.3%使用血管升压药,39.7%接受透析。
  • 84.1%的院内心脏骤停发生在ICU;最常见初始心律为无脉性电活动(58.7%)和无收缩(33.3%)。
  • 29%患者恢复自主循环但均短暂,院内死亡率为100%。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在本研究中,新型冠状病毒肺炎患者发生院内心脏骤停后,无论基线合并症、就诊时疾病严重程度和骤停地点如何,院内死亡率均为100%。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: There is limited data regarding outcomes after in-hospital cardiac arrest among coronavirus disease 2019 patients. None of the studies have reported the outcomes of in-hospital cardiac arrest in coronavirus disease 2019 patients in the United States. We describe the characteristics and outcomes of in-hospital cardiac arrest in coronavirus disease 2019 patients in rural Southwest Georgia.

DESIGN: Retrospective cohort study.

SETTING: Single-center, multihospital.

PATIENTS: Consecutive coronavirus disease 2019 patients who experienced in-hospital cardiac arrest with attempted resuscitation.

INTERVENTIONS: Attempted resuscitation with advanced cardiac life support.

MEASUREMENT AND MAIN RESULTS: Out of 1,094 patients hospitalized for coronavirus disease 2019 during the study period, 63 patients suffered from in-hospital cardiac arrest with attempted resuscitation and were included in this study. The median age was 66 years, and 49.2% were males. The majority of patients were African Americans (90.5%). The most common comorbidities were hypertension (88.9%), obesity (69.8%), diabetes (60.3%), and chronic kidney disease (33.3%). Eighteen patients (28.9%) had a Charlson Comorbidity Index of 0-2. The most common presenting symptoms were shortness of breath (63.5%), fever (52.4%), and cough (46%). The median duration of symptoms prior to admission was 14 days. During hospital course, 66.7% patients developed septic shock, and 84.1% had acute respiratory distress syndrome. Prior to in-hospital cardiac arrest, 81% were on ventilator, 60.3% were on vasopressors, and 39.7% were on dialysis. The majority of in-hospital cardiac arrest (84.1%) occurred in the ICU. Time to initiation of advanced cardiac life support protocol was less than 1 minute for all in-hospital cardiac arrest in the ICU and less than 2 minutes for the remaining patients. The most common initial rhythms were pulseless electrical activity (58.7%) and asystole (33.3%). Although return of spontaneous circulation was achieved in 29% patients, it was brief in all of them. The in-hospital mortality was 100%.

CONCLUSIONS: In our study, coronavirus disease 2019 patients suffering from in-hospital cardiac arrest had 100% in-hospital mortality regardless of the baseline comorbidities, presenting illness severity, and location of arrest.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Shah P, Smith H, Olarewaju A, et al. Is Cardiopulmonary Resuscitation Futile in Coronavirus Disease 2019 Patients Experiencing In-Hospital Cardiac Arrest? Crit Care Med. 2021. PMID: 33093278. doi:10.1097/CCM.0000000000004736

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。